HEADER TRANSFERASE 29-OCT-20 7AT9 TITLE STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (CSNK2A2 GENE TITLE 2 PRODUCT) IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR MB002 AND THE TITLE 3 ALPHAD-POCKET LIGAND 3,4-DICHLOROPHENETHYLAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, BIVALENT INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.LINDENBLATT,V.APPLEGATE,A.NICKELSEN,M.KLUSSMANN,I.NEUNDORF,C.GOETZ, AUTHOR 2 J.JOSE,K.NIEFIND REVDAT 3 09-FEB-22 7AT9 1 JRNL REVDAT 2 22-SEP-21 7AT9 1 JRNL REVDAT 1 04-AUG-21 7AT9 0 JRNL AUTH D.LINDENBLATT,V.APPLEGATE,A.NICKELSEN,M.KLUSSMANN, JRNL AUTH 2 I.NEUNDORF,C.GOTZ,J.JOSE,K.NIEFIND JRNL TITL MOLECULAR PLASTICITY OF CRYSTALLINE CK2 ALPHA ' LEADS TO JRNL TITL 2 KN2, A BIVALENT INHIBITOR OF PROTEIN KINASE CK2 WITH JRNL TITL 3 EXTRAORDINARY SELECTIVITY. JRNL REF J.MED.CHEM. V. 65 1302 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34323071 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00063 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.HOCHSCHERF, REMARK 1 AUTH 2 B.WITULSKI,Z.BOUAZIZ,C.MARMINON,M.BRETNER,M.LE BORGNE, REMARK 1 AUTH 3 J.JOSE,K.NIEFIND REMARK 1 TITL DIACRITIC BINDING OF AN INDENOINDOLE INHIBITOR BY CK2ALPHA REMARK 1 TITL 2 PARALOGS EXPLORED BY A RELIABLE PATH TO ATOMIC RESOLUTION REMARK 1 TITL 3 CK2ALPHA' STRUCTURES REMARK 1 REF ACS OMEGA V. 4 5471 2019 REMARK 1 REFN ESSN 2470-1343 REMARK 1 DOI 10.1021/ACSOMEGA.8B03415 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.JOSE,K.NIEFIND REMARK 1 TITL STRUCTURAL AND MECHANISTIC BASIS OF THE INHIBITORY POTENCY REMARK 1 TITL 2 OF SELECTED 2-AMINOTHIAZOLE COMPOUNDS ON PROTEIN KINASE CK2. REMARK 1 REF J MED CHEM V. 63 7766 2020 REMARK 1 REFN ISSN 1520-4804 REMARK 1 DOI 10.1021/ACS.JMEDCHEM.0C00587 REMARK 2 REMARK 2 RESOLUTION. 1.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 81.2 REMARK 3 NUMBER OF REFLECTIONS : 153804 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.129 REMARK 3 R VALUE (WORKING SET) : 0.129 REMARK 3 FREE R VALUE : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.7400 - 2.3200 1.00 17021 175 0.1418 0.1558 REMARK 3 2 2.3200 - 1.8400 1.00 17043 170 0.1192 0.1323 REMARK 3 3 1.8400 - 1.6100 1.00 16950 171 0.1032 0.1307 REMARK 3 4 1.6100 - 1.4600 0.99 16885 173 0.0968 0.1147 REMARK 3 5 1.4600 - 1.3600 0.99 16834 174 0.1018 0.1508 REMARK 3 6 1.3600 - 1.2800 0.98 16768 176 0.1180 0.1500 REMARK 3 7 1.2800 - 1.2100 0.97 16525 165 0.1443 0.1780 REMARK 3 8 1.2100 - 1.1600 0.80 13518 146 0.1684 0.2162 REMARK 3 9 1.1600 - 1.1200 0.61 10485 96 0.1912 0.2053 REMARK 3 10 1.1200 - 1.0800 0.41 7002 75 0.2271 0.2080 REMARK 3 11 1.0800 - 1.0500 0.19 3218 34 0.2703 0.3102 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.084 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 3108 REMARK 3 ANGLE : 1.163 4214 REMARK 3 CHIRALITY : 0.093 425 REMARK 3 PLANARITY : 0.009 544 REMARK 3 DIHEDRAL : 17.471 1216 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AT9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1292112054. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873127 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 154027 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.039 REMARK 200 RESOLUTION RANGE LOW (A) : 46.565 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.1 REMARK 200 DATA REDUNDANCY : 8.600 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 24.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 1.09600 REMARK 200 R SYM FOR SHELL (I) : 1.09600 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: ARCIMBOLDO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR COMPOSITION: 28 % (W/V) REMARK 280 PEG6000, 0.9 M LICL, 0.1 M, TRIS/HCL, PH 8.5; DROP COMPOSITION REMARK 280 PRIOR TO EQUILIBRATION: 0.01 ML RESERVOIR SOLUTION + 0.02 ML REMARK 280 CK2ALPHA' (MUTANT CYS336SER)/INHIBITOR MB002 MIXTURE (0.180 ML 6 REMARK 280 MG/ML CK2ALPHA'CYS336SER, 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5, REMARK 280 MIXED AND PRE-EQUILIBRATED WITH 0.02 ML 10 MM MB002 IN DIMETHYL REMARK 280 SULFOXIDE); THE ALPHAD-POCKET LIGAND 3,4-DICHLOROPHENETHYLAMINE REMARK 280 WAS INTRODUCED BY EXTENSIVE SOAKING., VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 334 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 127 -7.55 -140.44 REMARK 500 ILE A 128 159.42 56.48 REMARK 500 ASP A 157 44.13 -151.03 REMARK 500 ASP A 176 78.92 56.27 REMARK 500 ALA A 186 -0.78 73.87 REMARK 500 ALA A 194 159.84 63.51 REMARK 500 ALA A 194 163.93 63.51 REMARK 500 ASP A 206 30.27 71.43 REMARK 500 MET A 209 53.08 -90.67 REMARK 500 HIS A 235 74.61 -106.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 988 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A 989 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH A 990 DISTANCE = 6.32 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 514 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ILE A 95 O REMARK 620 2 HOH A 676 O 143.8 REMARK 620 3 HOH A 896 O 96.8 102.6 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 513 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 691 O REMARK 620 2 HOH A 715 O 71.8 REMARK 620 3 HOH A 726 O 94.7 160.3 REMARK 620 N 1 2 DBREF 7AT9 A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 7AT9 MET A -13 UNP P19784 INITIATING METHIONINE SEQADV 7AT9 GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 7AT9 SER A -11 UNP P19784 EXPRESSION TAG SEQADV 7AT9 SER A -10 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 7AT9 HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 7AT9 SER A -3 UNP P19784 EXPRESSION TAG SEQADV 7AT9 GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 7AT9 ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 7AT9 PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 7AT9 SER A 336 UNP P19784 CYS 336 CONFLICT SEQRES 1 A 364 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 364 PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG VAL SEQRES 3 A 364 TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR TRP SEQRES 4 A 364 ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN ASP SEQRES 5 A 364 ASP TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SEQRES 6 A 364 SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU SEQRES 7 A 364 ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS SEQRES 8 A 364 LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU ARG SEQRES 9 A 364 GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL LYS SEQRES 10 A 364 ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU TYR SEQRES 11 A 364 ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE LEU SEQRES 12 A 364 THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU LEU SEQRES 13 A 364 LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET HIS SEQRES 14 A 364 ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLN SEQRES 15 A 364 GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU SEQRES 16 A 364 PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL ALA SEQRES 17 A 364 SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR SEQRES 18 A 364 GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY SEQRES 19 A 364 CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO PHE SEQRES 20 A 364 PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG ILE SEQRES 21 A 364 ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR LEU SEQRES 22 A 364 LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN ASP SEQRES 23 A 364 ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN PHE SEQRES 24 A 364 ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU ALA SEQRES 25 A 364 LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SEQRES 26 A 364 GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO TYR SEQRES 27 A 364 PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER ALA SEQRES 28 A 364 ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA ARG HET 42J A 501 20 HET CL A 502 1 HET CL A 503 1 HET EDO A 504 10 HET EDO A 505 10 HET EDO A 506 10 HET EDO A 507 10 HET EDO A 508 10 HET EDO A 509 10 HET EDO A 510 10 HET 4B0 A 511 48 HET 42J A 512 20 HET NA A 513 1 HET NA A 514 1 HETNAM 42J 2-(3,4-DICHLOROPHENYL)ETHANAMINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM 4B0 3-(4,5,6,7-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL HETNAM NA SODIUM ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 42J 2(C8 H9 CL2 N) FORMUL 3 CL 2(CL 1-) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 12 4B0 C9 H7 BR4 N3 O FORMUL 14 NA 2(NA 1+) FORMUL 16 HOH *390(H2 O) HELIX 1 AA1 GLU A 15 ARG A 20 1 6 HELIX 2 AA2 SER A 21 ASP A 26 1 6 HELIX 3 AA3 TYR A 27 HIS A 30 5 4 HELIX 4 AA4 LYS A 75 LEU A 89 1 15 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 SER A 195 LYS A 199 5 5 HELIX 8 AA8 GLY A 200 VAL A 205 1 6 HELIX 9 AA9 TYR A 212 ARG A 229 1 18 HELIX 10 AB1 ASP A 238 GLY A 251 1 14 HELIX 11 AB2 GLY A 251 HIS A 263 1 13 HELIX 12 AB3 ASP A 267 ILE A 273 5 7 HELIX 13 AB4 ARG A 281 ILE A 286 5 6 HELIX 14 AB5 ASN A 290 VAL A 294 5 5 HELIX 15 AB6 SER A 295 LEU A 306 1 12 HELIX 16 AB7 ASP A 309 ARG A 313 5 5 HELIX 17 AB8 THR A 315 GLU A 321 1 7 HELIX 18 AB9 HIS A 322 TYR A 324 5 3 HELIX 19 AC1 PHE A 325 SER A 333 1 9 SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ASP A 100 SHEET 4 AA1 6 ARG A 65 LEU A 71 -1 N VAL A 67 O PHE A 114 SHEET 5 AA1 6 SER A 52 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 ARG A 48 -1 N LEU A 46 O VAL A 54 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O ARG A 173 N MET A 164 LINK O ILE A 95 NA NA A 514 1555 1555 2.89 LINK NA NA A 513 O BHOH A 691 1555 1555 2.38 LINK NA NA A 513 O HOH A 715 1555 1555 3.09 LINK NA NA A 513 O HOH A 726 1555 1555 2.85 LINK NA NA A 514 O HOH A 676 1555 1555 2.55 LINK NA NA A 514 O HOH A 896 1555 1555 2.83 CISPEP 1 GLU A 231 PRO A 232 0 -10.77 CRYST1 46.482 47.661 50.733 66.61 89.44 88.66 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021514 -0.000504 -0.000013 0.00000 SCALE2 0.000000 0.020987 -0.009073 0.00000 SCALE3 0.000000 0.000000 0.021475 0.00000